Schedule 13G ownership disclosure

Rocket Pharmaceuticals Inc

Security class unavailable · CUSIP: 77313F106

Event date: 2019-01-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,400,000
Percent of class
5.3500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-19-000300
Form type
SC 13G
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Jan 17, 2019
Reporting period
Jan 08, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub